Name
Biofidelity
What We Do
Biofidelity is a genomic technology company dedicated to improving and extending the lives of patients with cancer by enabling better targeting of therapies, early detection of treatment resistance and routine monitoring of treatment response.

Molecular profiling of tumors is especially critical for patients with lung cancer to access personalized oncology therapeutics. We developed simplified genomic profiling technology to provide rapid (2-day TAT), accessible, and cost-effective diagnostics informing actionable genomic variants. Aspyre Clinical Test for Lung covers 114 variants in 11 genes (ALK, BRAF, EGFR, ERBB2, KRAS, RET, ROS1, MET & NTRK1/2/3) including single nucleotide variants (SNV), insertions, deletions (indel), and gene fusions from tissue and plasma-derived cfDNA and cfRNA simultaneously. Aspyre Clinical Test for Lung enables physicians to robustly and quickly act on this information to inform clinical management, even in early stage disease.
Categories
Biotechnology, Imaging/Diagnostics, Thoracic
Address
5151 McCrimmon Parkway
Morrisville, NC 27560
United States